TOLERABILITY OF ADJUNCTIVE LACOSAMIDE IN PAEDIATRIC PATIENTS AGED 4 TO <16 YEARS WITH FOCAL SEIZURES: AN INTERIM POOLED ANALYSIS OF DATA FROM OPEN-LABEL TRIALS

被引：0
|
作者：
Yuen, N. [1 ]
Taeter, C. [2 ]
Beller, C. [1 ]
Daniels, T. [1 ]
Bozorg, A. [1 ]
机构：
[1] UCB Pharma, Raleigh, NC USA
[2] UCB Pharma, Braine Lalleud, Belgium
来源：
EPILEPSIA | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
p0725
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials
    Patel, Anup D.
    Badalamenti, Vincent
    Gasalla, Teresa
    Elmoufti, Sami
    Elshoff, Jan-Peer
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2020, 25 : 68 - 76
  • [2] Efficacy and tolerability of adjunctive lacosamide in patients aged <4 years with focal seizures
    Makedonska, Iryna
    Ng, Yu-Tze
    Beller, Cynthia
    Bozorg, Ali
    Csikos, Janos
    Mcclung, Carrie
    Moeltgen, Holger
    Farkas, Mark Kristof
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (03): : 768 - 779
  • [3] Safety, Tolerability, and Cognitive and Behavioral Effects of Long- term Adjunctive Lacosamide in Children and Adolescents with Focal Seizures: Pooled Analysis of Data from Open-label Trials
    Potter, B.
    de la Loge, C.
    Elmoufti, S.
    Roebling, R.
    Steiniger-Brach, B.
    Yuen, N.
    McClung, C.
    Pina-Garza, J.
    ANNALS OF NEUROLOGY, 2021, 90 : S130 - S131
  • [4] Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial
    Ferreira, Jose A.
    Le Pichon, Jean-Baptiste
    Abdelmoity, Ahmed T.
    Dilley, Deanne
    Dedeken, Peter
    Daniels, Tony
    Byrnes, William
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 71 : 166 - 173
  • [5] Safety And Efficacy Of Adjunctive Lacosamide In Chinese And Japanese Adult Epilepsy Patients With Focal Seizures: Interim Data From An Open-Label Extension Trial
    Inoue, Y.
    Du, X.
    Hoshii, N.
    Sasamato, H.
    EPILEPSIA, 2019, 60 : 62 - 62
  • [6] Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
    Liu, Edwin
    Dilley, Deanne
    McDonough, Belinda
    Stockis, Armel
    Daniels, Tony
    PEDIATRIC DRUGS, 2019, 21 (04) : 291 - 301
  • [7] SEIZURE FREEDOM IN ADULTS WITH PARTIAL-ONSET SEIZURES TREATED WITH ADJUNCTIVE LACOSAMIDE: POOLED ANALYSIS OF THREE OPEN-LABEL EXTENSION TRIALS
    Dimova, S.
    McShea, C.
    De Backer, M.
    EPILEPSIA, 2013, 54 : 173 - 174
  • [8] EFFICACY OF ADJUNCTIVE LACOSAMIDE (≤400 MG/DAY) IN COMPLEX PARTIAL AND SECONDARY GENERALIZED SEIZURES IN ADULTS WITH FOCAL EPILEPSY: POOLED ANALYSIS OF THREE OPEN-LABEL EXTENSION TRIALS
    Dimova, S.
    McShea, C.
    Doty, P.
    Werhahn, K. J.
    De Backer, M.
    EPILEPSIA, 2014, 55 : 182 - 182
  • [9] LONG-TERM SAFETY AND TOLERABILITY OF LACOSAMIDE FOR PARTIAL-ONSET SEIZURES: AN INTERIM EVALUATION OF PATIENTS EXPOSED TO LACOSAMIDE IN DOUBLE-BLIND AND OPEN-LABEL TRIALS
    Rosenfeld, William
    Rosenow, F.
    Isojarvi, J.
    Hebert, D.
    Doty, P.
    EPILEPSIA, 2009, 50 : 262 - 262
  • [10] Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures: An Interim Evaluation of Patients Exposed to Lacosamide in Double-Blind and Open-Label Trials
    Rosenfeld, William
    Rosenow, Felix
    Isojarvi, Jouko
    Hebert, David
    Doty, Pamela
    NEUROLOGY, 2010, 74 (09) : A452 - A453
12345